Hiva Kolodrubetz, NP, provides an engaging and detailed session on anti-diabetic medications, focusing on safe prescribing and effective management strategies. Highlighting pharmacological mechanisms, A1C goals, and patient-centered care,…
Associate Professor Mike Todorovic, AKA “Dr. Mike”, introduces the endocrine system, explaining how hormones act as chemical messengers released into the bloodstream by cells, tissues, and glands. He…
NEW YORK (Reuters Health) – Excessive weight, smoking, diabetes, and hypertension in mid-life are strongly correlated with the development of left ventricular (LV) hypertrophy, investigators report in an…
NEW YORK (Reuters Health) – Failure to get a full night’s sleep can lead to weight gain or compromise the beneficial effects of a reduced calorie diet on…
NEW YORK (Reuters Health) – As adjunct to standard wound care, external shock wave therapy (ESWT) can promote the healing of neuropathic diabetic foot ulcers, Italian researchers report.…
NEW YORK (Reuters Health) – Newly published research is challenging guidelines from the American College of Obstetricians and Gynecologists stating that all women, even those who are obese,…
NEW YORK (Reuters Health) – To minimize the risk of serious adverse pregnancy outcomes, women with type 1 diabetes should keep their preconceptional levels of glycosylated hemoglobin (A1C)…
NEW YORK (Reuters Health) – In men with diabetes, coffee consumption does not increase the risk of cardiovascular diseases or all-cause morality, according to a brief report in…
NEW YORK (Reuters Health) – Basic clinical information can identify individuals at high risk of developing diabetes within 10 years, and adding some lab values identifies those at…
NEW YORK (Reuters Health) – Daily self-monitoring of blood glucose levels by women with mild or diet-treated gestational diabetes is more effective than weekly office-based testing in reducing…
NEW YORK (Reuters Health) – Obstructive sleep apnea (OSA) is often undiagnosed, and therefore untreated, in obese patients with type 2 diabetes, according to research published in the…
NEW YORK (Reuters Health) – Treatment with fenofibrate can reduce the risk of amputation in people with type 2 diabetes by 36%, according to a report in the…
